Burning Rock Biotech Limi... (BNR)
3.00
-0.01 (-0.33%)
At close: Apr 14, 2025, 3:59 PM
2.95
-1.67%
After-hours: Apr 14, 2025, 03:59 PM EDT
-0.33% (1D)
| Bid | 2.62 |
| Market Cap | 30.78M |
| Revenue (ttm) | 510.88M |
| Net Income (ttm) | -427.55M |
| EPS (ttm) | -4.58 |
| PE Ratio (ttm) | -0.66 |
| Forward PE | -11.5 |
| Analyst | n/a |
| Ask | 3.4 |
| Volume | 13,416 |
| Avg. Volume (20D) | 9,491 |
| Open | 3.19 |
| Previous Close | 3.01 |
| Day's Range | 3.00 - 3.42 |
| 52-Week Range | 2.62 - 8.99 |
| Beta | 0.67 |
About BNR
Burning Rock Biotech Limited primarily develops and provides cancer therapy selection tests in the People's Republic of China. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company primarily offers next-generation sequencing-based cancer therapy selection and prognosis prediction tests applicable to a range of cancer types, including lung cancer, gastrointestina...
Industry Medical - Diagnostics & Research
Sector Healthcare
IPO Date Jun 12, 2020
Employees 786
Stock Exchange NASDAQ
Ticker Symbol BNR
Website https://www.brbiotech.com
3 weeks ago
-12.36%
Burning Rock Biotech shares are trading lower. The...
Unlock content with
Pro Subscription
4 months ago
+13.61%
Burning Rock Biotech shares are trading higher after the company reported a year-over-year increase in Q3 financial results.
